Industry Reports

Jiangsu Nhwa Pharmaceutical Corporation Ltd. (002262) - Financial and Strategic SWOT Analysis Review

Saturday, Sep 12, 2015

Jiangsu Nhwa Pharmaceutical Corporation Ltd. (Jiangsu) is a pharmaceutical company that develops medicine. The company research, develops and manufactures central nervous system medicines. It offers psychiatrical, anesthetic and neurological medicines including anti-anxiety agent, anti-psychopathic drug, antiepileptic drug, anti-depressant, hypnotic, intravenous anesthetics and respiratory excitant. Jiangsu’s products are used in the treatment of analgesics, depression, and other diseases. The company operates through production center, research and development center, marketing center, manufacturing sub-companies and commercial companies. It offers its products in the dosage forms of tablets, capsules, water injections, powder injections and granules. Jiangsu is headquartered in Xuzhou, China.

Read More>